Connection

David Ho to Spike Glycoprotein, Coronavirus

Back to Details
This is a "connection" page, showing publications David Ho has written about Spike Glycoprotein, Coronavirus.
David Ho
Connection Strength
0.508
Spike Glycoprotein, Coronavirus
  1. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021 05; 593(7857):130-135.
    View in: PubMed
    Score: 0.103
  2. SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease. Emerg Microbes Infect. 2020 Dec; 9(1):2091-2093.
    View in: PubMed
    Score: 0.101
  3. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020 08; 584(7821):450-456.
    View in: PubMed
    Score: 0.099
  4. Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure. 2021 07 01; 29(7):655-663.e4.
    View in: PubMed
    Score: 0.026
  5. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021 07; 595(7866):278-282.
    View in: PubMed
    Score: 0.026
  6. Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell Host Microbe. 2021 05 12; 29(5):747-751.e4.
    View in: PubMed
    Score: 0.026
  7. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe. 2021 05 12; 29(5):819-833.e7.
    View in: PubMed
    Score: 0.026
  8. Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains. Cell Host Microbe. 2020 12 09; 28(6):867-879.e5.
    View in: PubMed
    Score: 0.025
  9. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles. Cell Host Microbe. 2020 12 09; 28(6):880-891.e8.
    View in: PubMed
    Score: 0.025
  10. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes. Cell Rep. 2020 10 27; 33(4):108322.
    View in: PubMed
    Score: 0.025
  11. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol. 2005 Mar; 79(5):2678-88.
    View in: PubMed
    Score: 0.009
  12. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature. 2021 09; 597(7878):703-708.
    View in: PubMed
    Score: 0.007
  13. Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus. Appl Microbiol Biotechnol. 2007 Oct; 76(5):1131-6.
    View in: PubMed
    Score: 0.002
  14. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus. J Virol. 2007 May; 81(9):4694-700.
    View in: PubMed
    Score: 0.002
  15. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine. 2005 Oct 10; 23(42):4959-68.
    View in: PubMed
    Score: 0.002
  16. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. J Virol. 2005 Sep; 79(18):11638-46.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.